1.Investigation of the expression of proliferating cell nuclear antigen of retinal pigment epithelial cells after experimental retinal detachment and reattachment in cats
Tiecheng LIU ; Zhizhong MA ; Maonian ZHANG ; Baichen LIU ; Suozhu SHI ; Changguan WANG ; Gaokui ZHANG
Chinese Journal of Ocular Fundus Diseases 1996;0(01):-
Objective To examine the expression of proliferating cell nuclear antigen (PCNA) of retinal pigment epithelial (RPE) cells, thus assessing the role of mechanism of contact inhibition playing in the process of experimental retinal detachment and reattachemnt. Methods Retinal detachment was produced in 72 cats by subretinal injection of 0.25% solution of healon through a micropipette three weeks after extracapsular lens extraction and vitrectomy. Some of the detached retinae were reattached 24 hours later. At different time, the cats were killed and eye globes were fixed and embeded in paraffin. Histologic sections were processed for immunohistochemistry examination using an antibody to detect PCNA protein. Labeled RPE cells were identified, and the proliferation was quantified in detached and un detached retinae of detachment group, and also in reattached retinae of reattachment group. The comparsion of PCNA labeled RPE cells in different groups were analyzed by ANOVA. Results In detached regions of detachment group, PCNA expression of RPE cells occured within 24 hours, and reached a maximum after 5 6 days, then gradually declined to barely detectable levels after 20 days. Similar tendency was found in reattached retinae, but the number of PCNA labeled RPE cells was obviously small. Fewer PCNA labeled RPE cells were found in regions of un detached retinae in detachment group. The difference of these three groups was significant. Conclusion Proliferation of RPE cells is induced when they lose contact with neural retina, but inhibited after neural retina reattached to RPE cells. It suggests that the mechanism of contact inhibition plays a role in the proliferative process after retinal detachment and reattachment.
2.Compared empirical evaluation of artery stiffness by echo-tracking and M-mode ultrasonography
Chaoyang WEN ; Jie TANG ; Yuexiang WANG ; Zhigang CHENG ; Qian LIN ; Gaokui ZHANG
Chinese Journal of Ultrasonography 1993;0(03):-
Objective To study the worth of echo-tracking and M-echo in evaluating artery stiffness comparatively.Methods Fifty two rabbits were divided into 4 groups randomly:control group 1,hypercholesterinemia group,control group 2,and artherosclerosis group,there were 13 rabbits in each group.The rabbits were bred with normal or 2% cholesterol animal feeds according to their groups.The femoral artery blood pressure were measured with catheter.Artery stiffness of abdomen aorta of every rabbit was evaluated by echo-tracking and M-echo at the baseline and the end of the study by 2 doctors,and each doctor did twice.Results All the rabbits of artherosclerosis group had lipid plaques in the thorax and abdomen aortas,and the interior elastic fibers board under the plagues were disrupted.Echo-tracking was more stable and sensitive than M-echo in evaluating artery stiffness.pressure-strain elastic modulus(E?) and stiffness index(?) were sensitive stiffness indexes,but arterial compliance(AC) was not.The indexes of artery stiffness evaluated by echo-tracking with short view of the artery were stable too,but not sensitive compared with long view.E? was relative to diastolic diameter of artery and HDL-C positively(P0.05).Conclusions Echo-tracking is more stable and sensitive than Mecho in evaluation of artery stiffness,long view of the artery should be applied in the evaluation of artery stiffness with the technique of echo-tracking.E? and ? were sensitive artery stiffness indexes,but AC was not.
3.Effect of leg-length discrepancy after total hip arthroplasty on collapse of the contralateral hip in bilateral steroid-induced avascular necrosis of the femoral head
Gaokui ZHANG ; Yangquan HAO ; Chen YANG ; Wenxing YU ; Yufeng LU ; Xuechao YUAN ; Chao LU
Journal of Chinese Physician 2021;23(1):34-38
Objective:To study the collapse of the contralateral femoral head after the total hip arthroplasty (THA) in patients with bilateral steroid-induced femoral head necrosis leg-length discrepancy (LLD) influences.Methods:A total of 108 patients with bilateral steroid-induced femoral head necrosis who were treated in Honghui Hospital Affiliated to Xi′an Jiaotong University from June 2014 to June 2016 underwent THA surgery on the hip joints that had symptoms and developed to Association Research Circulation Osseous (ARCO) Ⅲ. At the same time, the non-surgical hip-preserving treatment of the non-collapsed femoral head developed to the ARCO Ⅱ stage was performed. The follow-up period was 2 years, and 98 cases were finally included. According to the size of the leg-length discrepancy [LLD<3 mm group ( n=50), LLD≥3 mm group ( n=48)] and the type of leg-length discrepancy[non collapse side longer group ( n=58) and shorter group ( n=58)], the collapse of the femoral head and the THA were observed. Results:Finally, a total of 56 cases of femoral head collapse occurred in the non collapse side of the hip, of which 50 cases underwent THA within 24 months. There were significant statistical differences in THA and femoral head collapse between LLD<3 mm group and LLD≥3 mm group, non collapse side longer group and non collapse side shorter group ( P<0.05). The 2-year survival rate without collapse in the LLD<3 mm group and LLD≥3 mm group were 52.1% and 34.0%, respectively, and the 2-year survival rates in the longer and shorter non-collapsed limb groups were 56.9% and 22.5%, respectively. Compared with patients with moderate lesions, the survival rate of femoral heads in patients with larger lesions was lower ( OR: 4.25, 95% CI: 1.55-11.26; P=0.003). LLD<3 mm group ( OR: 0.24, 95% CI: 0.06-0.50; P<0.01) or non collapse side longer group ( OR: 0.13, 95% CI: 0.04-0.29; P<0.01) had lower risk of contralateral femoral head collapse after THA. Conclusions:For patients with bilateral steroid-induced femoral head necrosis who have collapsed lateral THA, postoperative leg-length discrepancy extremities is a potential risk factor for collapse of non-collapsed femoral head. LLD<3 mm and avoiding shortening of the uncollapsed limb may reduce the risk of collapse of the uncollapsed femoral head.
4.Multicenter controlled randomized clinical trial of akatinol memantine for treatment of Aizheimer's disease
Yan CHENG ; Nan ZHANG ; Hongjian DU ; Haibo CHEN ; Dantao PENG ; Xiaojie CAI ; Shifu XIAO ; Xia LI ; Cui MA ; Yaqing FENG ; Xuean MO ; Zongliang GAO ; Gang ZHAO ; Gaokui ZHANG
Chinese Journal of Neurology 2009;42(4):268-272
Objective To evaluate the clinical efficacy and safety of akatinol memantine in the treatment of Alzheimer's disease (AD).Methods Two hundred and forty-one patients with AD were randomly assigned to receive 10 mg of donepezil daily or 20 mg of memantine daily for 24 weeks.The primary efficacy variables were the Clinician' s Interview-Based Impression of Change Plus (CIBIC-Plus),the Alzheimer Disease Assessment Scale-cognition (ADAS-cog) and the Activities of Daily Living (ADL).The secondary efficacy variables were the Neuropsychiatric Inventory (NPI) and the Mini-Mental Status Examination (MMSE).Results Two hundred and seven patients completed the study and were evaluated at week 24.Both memantine and donepezil had significant efficacies at the end point, according to the ADAS-cog, the ADL, the NPI and the MMSE.Patients receiving memantine had a similar outcome as those receiving donepezil, according to the results of all the variables changes (CIBIC-Plus: memantine 3.4±0.8vs donepezil 3.5±0.8; ADAS-cog: memantine-4.7±5.8 vs donepezil-4.6±6.5; ADL: memantine -2.4±6.7 vs donepezil-2.2±5.3 ; NP1: memantine-5.8±9.0 vs donepezil-3.1±8.5 ; MMSE:memantine 1.7±3.1 vs donepezil 1.8±2.8, all P >0.05).The adverse events were as following: donepezil group 41.88% and memanintine group 30.58%.Conclusion The memantine as a new drug for AD, has the similar efficacy as donepezil, and it is safe.
5.Safety assessment in radomized controlled clinical trials.
Yuxiu LIU ; Chen YAO ; Feng CHEN ; Gaokui ZHANG ; Jielai XIA ; Qiquang CHEN ; Binghua SU
National Journal of Andrology 2004;10(1):74-79
OBJECTIVETo introduce some methods of safety assessment in randomized controlled clinical trials.
METHODSRecent advances and current parctice in normalized safety assessment were reviewed and relevant data analyzed. RESTULTS: The statistical issues including analysis and presentation of adverse events data and laboratory data were involved and summed up.
CONCLUSIONWith the progressive development of randomized controlled clinical trials in China, the methods introduced in this paper are sure to prove of consultative value for the safety assessment.
Humans ; Randomized Controlled Trials as Topic ; adverse effects ; methods ; Safety